Literature DB >> 24790108

Mis-regulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules.

Diogo B Peruchetti1, Jie Cheng2, Celso Caruso-Neves3, William B Guggino4.   

Abstract

High albumin concentrations in the proximal tubule of the kidney causes tubulointerstitial injury, but how this process occurs is not completely known. To address the signal transduction pathways mis-regulated in renal injury, we studied the modulation of mammalian target of rapamycin (mTOR) complexes by physiologic and pathophysiologic albumin concentrations in proximal tubule cells. Physiologic albumin concentrations activated the PI3K/mTORC2/PKB/mTORC1/S6 kinase (S6K) pathway, but pathophysiologically high albumin concentrations overactivated mTORC1 and inhibited mTORC2 activity. This control process involved the activation of ERK1/2, which promoted the inhibition of TSC2 and activation of S6K. Furthermore, S6K was crucial to promoting the over activation of mTORC1 and inhibition of mTORC2. Megalin expression at the luminal membrane is reduced by high concentrations of albumin. In addition, knockdown of megalin mimicked all the effects of pathophysiologic albumin concentrations, which disrupt normal signal transduction pathways and lead to an overactivation of mTORC1 and inhibition of mTORC2. These data provide new perspectives for understanding the molecular mechanisms behind the effects of albumin on the progression of renal disease.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Albumin; Cell Signaling; Epithelium; Receptor Regulation; mTOR Complex (mTORC)

Mesh:

Substances:

Year:  2014        PMID: 24790108      PMCID: PMC4059122          DOI: 10.1074/jbc.M114.549717

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.

Authors:  Brian Magnuson; Bilgen Ekim; Diane C Fingar
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site.

Authors:  Masao Saitoh; Nicholas Pullen; Paul Brennan; Doreen Cantrell; Patrick B Dennis; George Thomas
Journal:  J Biol Chem       Date:  2002-03-25       Impact factor: 5.157

3.  Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate.

Authors:  Ji Young Lee; Jai Won Chang; Won Seok Yang; Soon Bae Kim; Su Kil Park; Jung Sik Park; Sang Koo Lee
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

4.  Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice.

Authors:  Kostas Stylianou; Ioannis Petrakis; Vasiliki Mavroeidi; Stavros Stratakis; George Kokologiannakis; Eirini Lioudaki; Christina Liotsi; Nikos Kroustalakis; Eleftheria Vardaki; Spyros Stratigis; Kostas Perakis; John Kyriazis; Lydia Nakopoulou; Eugene Daphnis
Journal:  Nephrol Dial Transplant       Date:  2012-01-30       Impact factor: 5.992

5.  Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

Authors:  B T Navé; M Ouwens; D J Withers; D R Alessi; P R Shepherd
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Albumin stimulates p44/p42 extracellular-signal-regulated mitogen-activated protein kinase in opossum kidney proximal tubular cells.

Authors:  R Dixon; N J Brunskill
Journal:  Clin Sci (Lond)       Date:  2000-03       Impact factor: 6.124

7.  Interstitial nephritis induced by protein-overload proteinuria.

Authors:  A A Eddy
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

8.  Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats.

Authors:  Akihiro Tojo; Maristela Lika Onozato; Hidetake Kurihara; Tatsuo Sakai; Atsuo Goto; Toshiro Fujita
Journal:  Hypertens Res       Date:  2003-05       Impact factor: 3.872

9.  Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells.

Authors:  Kiho Takaya; Daisuke Koya; Motohide Isono; Toshiro Sugimoto; Takeshi Sugaya; Atsunori Kashiwagi; Masakazu Haneda
Journal:  Am J Physiol Renal Physiol       Date:  2003-01-07

10.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

View more
  12 in total

1.  O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

Authors:  Rodrigo Pacheco Silva-Aguiar; Nathália C F Bezerra; Miguel C Lucena; Gabriela M Sirtoli; Roberto T Sudo; Gisele Zapata-Sudo; Christina M Takiya; Ana Acacia S Pinheiro; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

2.  Altered mTOR signalling in nephropathic cystinosis.

Authors:  Ekaterina A Ivanova; Lambertus P van den Heuvel; Mohamed A Elmonem; Humbert De Smedt; Ludwig Missiaen; Anna Pastore; Djalila Mekahli; Greet Bultynck; Elena N Levtchenko
Journal:  J Inherit Metab Dis       Date:  2016-02-24       Impact factor: 4.982

Review 3.  tRNA fragmentation and protein translation dynamics in the course of kidney injury.

Authors:  Iadh Mami; Nicolas Pallet
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

4.  High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation.

Authors:  Diogo de Barros Peruchetti; Rodrigo Pacheco Silva-Aguiar; Gabriela Marques Siqueira; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

5.  Cubilin-, megalin-, and Dab2-dependent transcription revealed by CRISPR/Cas9 knockout in kidney proximal tubule cells.

Authors:  Kimberly R Long; Youssef Rbaibi; Corry D Bondi; B Rhodes Ford; Amanda C Poholek; Cary R Boyd-Shiwarski; Roderick J Tan; Joseph D Locker; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-08

6.  Lithium ameliorates tubule-interstitial injury through activation of the mTORC2/protein kinase B pathway.

Authors:  Douglas E Teixeira; Diogo B Peruchetti; Leandro S Silva; Rodrigo P Silva-Aguiar; Morgana B Oquendo; João Luiz Silva-Filho; Christina M Takiya; José Henrique Leal-Cardoso; Ana Acacia S Pinheiro; Celso Caruso-Neves
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

7.  The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson's Disease.

Authors:  Mahesh Ramalingam; Yu-Jin Huh; Yun-Il Lee
Journal:  Front Neurosci       Date:  2019-09-24       Impact factor: 4.677

8.  Diabetic rats present higher urinary loss of proteins and lower renal expression of megalin, cubilin, ClC-5, and CFTR.

Authors:  Miriam F Figueira; Raquel C Castiglione; Carolina M de Lemos Barbosa; Felipe M Ornellas; Geórgia da Silva Feltran; Marcelo M Morales; Rodrigo N da Fonseca; Jackson de Souza-Menezes
Journal:  Physiol Rep       Date:  2017-07

9.  LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion.

Authors:  Marcelle C Ribeiro; Diogo B Peruchetti; Leandro S Silva; João L Silva-Filho; Mariana C Souza; Maria das Graças Henriques; Celso Caruso-Neves; Ana Acacia S Pinheiro
Journal:  Front Mol Biosci       Date:  2018-07-18

10.  The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury.

Authors:  Leandro S Silva; Diogo B Peruchetti; Rodrigo P Silva-Aguiar; Thiago P Abreu; Beatriz K A Dal-Cheri; Christina M Takiya; Mariana C Souza; Maria G Henriques; Ana Acacia S Pinheiro; Celso Caruso-Neves
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.